Progenics Pharma (PGNX) Sends Letter to Shareholders

October 9, 2019 4:34 PM

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX), an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and follow ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found